Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,347,713
+$666,574 QoQ
Shares Held
97,013
-5.1% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 193 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. GLUE ranks #110 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in GLUE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,347,713 | 97,013 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,681,139 | 102,197 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $5,679,498 | 362,213 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $725,423 | 97,898 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $294,903 | 65,389 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $164,003 | 35,346 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $89,157 | 12,847 | Shares | Defined | 2025-02-13 | |
| 2023-12-31 | $59,426 | 10,518 | Shares | Defined | 2024-02-13 | |
| 2022-09-30 | $81,723 | 10,003 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||